Braskem (NYSE:BAK) Stock Price Target Cut by UBS Group

Braskem (NYSE:BAK – Get Free Report) had its price objective lowered by analysts at UBS Group from $1.50 to $0.75 in a research note issued to investors on Thursday, Benzinga reports. The brokerage currently has a “sell” rating on the stock. UBS Group‘s target price indicates a potential upside of 0.89% from the stock’s previous close.

Several other research firms have also recently commented on BAK. HSBC cut Braskem from a “buy” rating to a “hold” rating and reduced their target price for the stock from $6.50 to $1.50 in a research report on Monday, September 28th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Braskem in a report on Thursday, October 15th. Finally, Wall Street Zen upgraded Braskem to a “hold” rating in a research report on Saturday, October 17th. Three analysts have rated the stock with a Hold rating and five have given a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Strong Sell” and an average price target of $2.41.

View Our Latest Stock Analysis on Braskem

Braskem Price Performance

BAK opened at $0.74 on Thursday. The firm has a market capitalization of $296.32 million, a P/E ratio of -0.25 and a beta of 1.68. Braskem has a one year low of $0.73 and a one year high of $5.39. The company has a fifty day moving average price of $1.45 and a 200-day moving average price of $2.84.

Braskem (NYSE:BAK – Get Free Report) last issued its quarterly earnings data on Friday, November 13th. The company reported ($0.52) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.54). The business had revenue of $3.78 billion during the quarter, compared to analysts’ expectations of $3.64 billion. Braskem had a negative return on equity of 45.63% and a negative net margin of 8.40%. On average, analysts expect that Braskem will post -0.33 earnings per share for the current year.

Hedge Funds Weigh In On Braskem

A number of institutional investors have recently made changes to their positions in the stock. Marshall Wace LLP lifted its holdings in shares of Braskem by 93.6% during the 3rd quarter. Marshall Wace LLP now owns 3,908,760 shares of the company’s stock worth $5,668,000 after acquiring an additional 1,889,378 shares during the last quarter. Goldman Sachs Group Inc. grew its position in Braskem by 1,729.5% in the third quarter. Goldman Sachs Group Inc. now owns 931,022 shares of the company’s stock worth $1,350,000 after acquiring an additional 880,133 shares in the last quarter. Brooklands Fund Management Ltd purchased a new position in Braskem in the first quarter worth $2,013,000. Private Advisor Group LLC bought a new position in Braskem in the third quarter valued at $156,000. Finally, Ramsey Quantitative Systems increased its stake in Braskem by 24.7% in the third quarter. Ramsey Quantitative Systems now owns 79,000 shares of the company’s stock valued at $115,000 after acquiring an additional 15,627 shares during the last quarter.

About Braskem

(Get Free Report)

Braskem is a Brazilian petrochemical company that produces thermoplastic resins and basic petrochemicals used in packaging, construction, automotive manufacturing, consumer goods and other industries. Its products include polyethylene, polypropylene and polyvinyl chloride, as well as chemical building blocks such as ethylene and propylene. The company also makes bio-based plastics, including polyethylene produced from sugarcane-derived ethanol and marketed under its I’m green brand. These materials are designed to serve applications similar to those of conventional plastics.

See Also

Analyst Recommendations for Braskem (NYSE:BAK)

Receive News & Ratings for Braskem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Braskem and related companies with MarketBeat.com's FREE daily email newsletter.